FindTrial
Sign In

Dexmedetomidine to prevent Emergence delirium

Role of single bolus dose Dexmedetomidine in providing smooth extubation and prevention of emergence delirium in paediatric ocular surgeries: A single blind randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025744
Enrollment
80
Registered
2020-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F989- Unspecified behavioral and emotional disorders with onset usually occurring in childhood and adolescence

Interventions

None listed

Sponsors

Vision Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All American Society of Anesthesiologists (ASA) Grade I, II. Age 3-12 yrs scheduled for ocular surgeries.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery 2. Children with intelectual disability 3. Children with neurological diseases 4. Renal or Hepatic disease 5. Children with cardiac or respiratory diseases 6. Allergy to Dexmedetomidine 7. Obese children

Design outcomes

Primary

MeasureTime frame
Incidence of ED within 30 minutes after extubationTimepoint: Incidence of ED within 30 minutes after extubation—

Secondary

MeasureTime frame
The incidence of â?¢ Pain, â?¢ Extubation time, â?¢ Post-anesthesia care unit (PACU) length of stay after extubation, â?¢ Adverse events such as PONV, laryngospasm, severe coughing, oxygen desaturation and bradycardiaTimepoint: 7 months—

Countries

India

Contacts

Public ContactDr Sonali Raman

Sankara Nethralaya

drsrn@snmail.org9444878708

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026